Skip to main content

Visit our other sites

jnj.com
jnjinnovation network
Quickfire Challenges

Main navigation

Home
About us
Partner with us
Blog
News
Challenges
Video hub
Connect with Us

News

Maintabs

All news
Press releases
In the media
Partner news
Social
Other News

Article view
List view

Refine by

Refine by

Type

(-) In the media
(-) Partner news

Period

2021
2020
2019
2018

Jan
Feb
Mar
Apr
May
(-) Jun
Jul
Aug
Sep
Oct
Nov
Dec

Locations & regions

(-) EMEA
Global

Focus area

(-) Innovation
(-) Pharmaceuticals

Clear filters

News

Johnson & Johnson: The Leading Healthcare Group at the Forefront of Open Innovation

Read full story

Apollo Therapeutics Completes $145 Million Financing Led by Patient Square Capital to Expand and Advance Portfolio-Based Drug Development

Read full story

Michael Hübner – New Venture Lead, Johnson & Johnson Innovation Switzerland

Read full story

Imec collaborates with Janssen to advance precision medicine to treat and eliminate disease

Read full story

Medicines Discovery Catapult, MQ: Transforming mental health and Alzheimer’s Research UK announce an innovative drug discovery consortium with industry, supported by the Wellcome Trust.

Read full story

Pharma’s New R&D Models: Federating Innovation with Paul Stoffels M.D.

Read full story

Sidebar

Currently trending

Currently trending

Locus Biosciences Announces $35 Million Financing
VantAI Announces Multi-Year Protein Degrader Discovery Collaboration with Janssen
Bioasis Enters Into Research Collaboration With Janssen
Rondo Therapeutics Closes $67 Million Series A Financing to Advance Next-Generation Immuno-Oncology Platform for Solid Tumors
Biocom conference charts prospects for life sciences industry amid stock market volatility
Remix Therapeutics Enters Collaboration with Janssen to Advance Small Molecule Therapeutics Using REMaster Drug Discovery Platform to Modulate RNA Processing
VerImmune Inc Announces Research Collaboration with Janssen to Leverage its Unique Immuno-oncology Therapeutic Platform
Mersana Therapeutics Announces Research Collaboration and License Agreement with Janssen to Advance Novel Antibody-Drug Conjugates
CRISPR Therapeutics and ViaCyte, Inc. Announce First Patient Dosed in Phase 1 Clinical Trial of Novel Gene-Edited Cell Replacement Therapy for Treatment of Type 1 Diabetes (T1D)
Navitor Pharmaceuticals Announces Janssen Has Acquired Anakuria Therapeutics, Inc.

Trending

Trending

A JLABS Collaboration: DC4U

A JLABS Collaboration: Neurocast

Johnson & Johnson Innovation: Our Partnership Story